Lung TransplantationBronchiolitis ObliteransHeart-Lung TransplantationGraft RejectionLungTransplantationKidney TransplantationCytomegalovirus InfectionsImmunosuppressive AgentsPostoperative ComplicationsLung DiseasesPrimary Graft DysfunctionHeart TransplantationGraft SurvivalOrgan TransplantationImmunocompromised HostBronchoalveolar Lavage FluidTransplantation, HomologousTissue DonorsCytomegalovirusCollagen Type VBronchoalveolar LavageGanciclovirCyclosporineRetrospective StudiesBurkholderia gladioliMycosesImmunosuppressionTransplantsOpportunistic InfectionsTreatment OutcomeLiver TransplantationTime FactorsBonding, Human-PetBronchoscopyTacrolimusLung NeoplasmsInvasive Pulmonary AspergillosisAntifungal AgentsRisk FactorsAspergillosisAntiviral AgentsCystic FibrosisFollow-Up StudiesBiopsyTriazolesLung Diseases, FungalFatal OutcomeProspective StudiesBronchiLung InjuryVirus DiseasesCohort StudiesMycophenolic AcidParamyxoviridae InfectionsTransplantation ImmunologyCarcinoma, Non-Small-Cell LungIncidenceRespiratory AspirationBone Marrow TransplantationRespiratory Function TestsTissue and Organ ProcurementSyndromeRespiratory Tract InfectionsBiological MarkersSurvival AnalysisForced Expiratory VolumeLiving DonorsCase-Control StudiesWaiting ListsViral LoadLung Diseases, InterstitialBK VirusAcute Lung InjuryPrognosisLymphoproliferative DisordersProportional Hazards ModelsDNA, ViralPyrimidinesStatistics, NonparametricPulmonary FibrosisPilot ProjectsPostoperative PeriodHematopoietic Stem Cell TransplantationPolyomavirus InfectionsLiver FailureSurvival RateKidney Failure, ChronicIsoantibodiesPancreas TransplantationHistocompatibility TestingCadaverSeverity of Illness IndexLung Volume MeasurementsAcute DiseaseHLA AntigensDrug Therapy, CombinationGraft vs Host DiseaseKidneySirolimus